The honest bottom line is that the evidence for BPC-157 is not there yet not that it has been disproven, but that it has never been properly tested in people at all
Also, an earlier study, published in the New England Journal of Medicine , showed that acetaminophen and NSAID use was associated with risk of end-stage kidney disease, but aspirin use was not (Perneger 1994)
They also offer testosterone treatments (enclomiphene, oral TRT, injectable TRT) and longevity medications (metformin, rapamycin, NAD+), though those fall outside the GLP-1 program pricing
Our structure provides insights into the molecular basis of biased agonism
GLP-1 RAs are promising drugs that seem to be useful in the reduction of some neurological complications of diabetes
The way semaglutide works for kidney-related risk reduction is not fully understood